Skip to content

Nathan Menke

Department of Psychiatry, Michigan Medicine, University of Michigan, United States. Electronic address: menkena@med.umich.edu.

1 paper in the library · 4 citations · publishing 2025

Papers

Ketamine: An emerging agent in the management of neuropsychiatric disorders.

Asian journal of psychiatry April 1, 2025 Nathan Menke, Elizabeth Hoffman, Kelsey Gaylor et al. 4 citations

Ketamine's unique properties—including its safety, modulation of multiple neurotransmitter systems, and ability to promote neuroplastic changes—make it promising for neuropsychiatric disorders beyond anesthesia. This overview discusses its emerging uses in treating substance use disorders (alcohol, cannabis, cocaine, opioids), withdrawal syndromes (opioid and alcohol), acute and chronic pain, and severe psychomotor agitation. While ketamine's role in depression and suicidality is well established, the paper focuses on these less common indications.